Loading, please wait...
The University of Texas College of Pharmacy welcomes you to the 34th Psychiatric Pharmacotherapy Update. This CE activity offers 20+ hours of psychiatric focused continuing education for pharmacists, physicians, advance practice nurses, nurse practitioners, social workers, counselors and psychologists.
|
TWO WAYS TO ATTEND • ONE REGISTRATION •
THEN FULL ON-DEMAND PROGRAM STARTING IN DECEMBER!
|
|
|
|
|
|
|
|
|
Date: Oct 13, 2022 08:00 AM - Oct 14, 2022 04:30 AM
Registration closes on Oct 31, 2022 12:00 AM
|
Welcome to the 34th Psychiatric Pharamcotherapy Update
   |
 In-Person Check-In |
|
Breakfast |
|
34th Psychiatric Pharamcotherapy Update Opening Remarks and Welcome
|
|
Psychopharmacology Myths and Facts Tawny Smith, Pharm.D., BCPP.
Associate Professor of Psychiatry The University of Texas at Austin Dell Medical School Marisa S. P. Toups, M.D.
Physiatrist / Owner, Singularity Psychiatry and Mental Health Affiliate Assistant Professor UT Southwestern Medical School Department of Psychiatry |
Dr. Tawny Smith: After graduating with her Pharm.D. degree, Dr. Smith completed a psychiatric pharmacy residency and clinical sciences fellowship in mental health outcomes at The University of Texas at Austin College of Pharmacy. She is a board certified psychiatric pharmacist currently serving as an Associate Professor of Psychiatry for The University of Texas at Austin (UT), Dell Medical School. She also maintains an adjunct faculty appointment with the UT-College of Pharmacy. Dr. Smith has outpatient practices in UT Health Austin Women’s Reproductive Mental Health and Bipolar Disorder clinics at the Mulva Clinic for the Neurosciences. She also practices at Ascension Seton Shoal Creek Hospital in Austin, where she runs the psychopharmacology consult service. She serves as one of the core faculty for the DMS psychiatry residency program where she has been awarded several teaching awards. She has delivered numerous educational presentations to the community and other health professionals at national and international conferences throughout her career. She has over 80 published abstracts, peer reviewed articles and book chapters in the area of psychiatric pharmacy. She is an active member of the American Association for Psychiatric Pharmacists (AAPP) and finished her 3-year term on the Board of Directors in June 2022. She remains active in her community and most recently she was elected to serve on the Board of Directors for the Austin Clubhouse.
Disclosure: Dr. Smith has no financial relationship(s) to disclose.
Dr. Marisa Toups is a clinician scientist specializing in the study of the interplay between physical and mental functions in health and disease. Her work focuses on understanding the effects of medical illness, particularly chronic inflammatory disorders, on mood and function. She completed a clinical research fellowship at the Center for Depression Research and Clinical Care at UT Southwestern in Dallas, TX and is an expert in the management of treatment resistant depression with a special interest in patients with co-morbid autoimmune and metabolic disorders. She also has extensive experience in clinical trials developing new ways of assessing and treating depression. Dr. Toups’ current research focuses on understanding specific mechanisms of bi-directional communication between the brain and immune system. Imbalance in this communication increases the risk of depression, as well as chronic inflammatory disorders such as diabetes. Dr. Toups is using genomic, gene expression, and metabolic analyses to better understand why some people are more vulnerable to this maladaptive pattern of brain-immune function with the ultimate goal of identifying targets for future therapies.
Disclosure: Dr. Toups has no financial relationship(s) to disclose.
|
Autism Update Speaker TBA
Title Title |
There has been a change in the speaker for this session. Faculty information coming soon.
Disclosure:
|
Break |
|
Management of Serious Mental Illness and Intellectual Developmental Disabilities Stella J Logan, MSN, PMHCNS-BC, PMHNP-BC
Psychiatric-Mental Health Clinical Nurse Specialist and Nurse Practitioner Psychiatric Associates of Central Texas |
Stella Logan graduated with her BSN from the University of Cincinnati. After working as an ICU nurse, she went on to obtain her MSN with clinical specialty in psychiatric-mental health nursing from Case Western Reserve University in Cleveland Ohio. She worked as a Clinical Nurse Specialist in a variety of inpatient, outpatient, private and public facilities in Ohio, Indiana and Oregon, and served on the faculty at Oregon Health Sciences University School of Nursing. She moved to Texas in 1991, and after working in school health joined the faculty at the University of Texas at Austin School of Nursing. She obtained a post-masters certificate as a FPMHNP from the University of Texas at Arlington after which she was instrumental in the development of the UT Austin PMHNP program. She continues to serve as an affiliate faculty at UT Austin School of Nursing, has a clinical practice focusing on people with serious mental illness and intellectual disabilities, and maintains involvement in various professional organizations at the local, state, and national levels.
Disclosure: Stella Logan has no financial relationship(s) to disclose.
|
Is Psychedelic Psychiatry Really Going to Change Care? Greg Fonzo, PhD
Assistant Professor and Co-Director
Center for Psychedelic Research and Therapy
Department of Psychiatry and Behavioral Sciences
The University of Texas at Austin Dell Medical School |
Greg Fonzo, Ph.D., is an Assistant Professor and Co-Director of the Center for Psychedelic Research and Therapy in the Department of Psychiatry and Behavioral Sciences at The University of Texas at Austin Dell Medical School. He completed his Ph.D. in Clinical Psychology at the San Diego State University/University of California-San Diego Joint Doctoral Program. He completed his postdoctoral fellowship in bio-behavioral research at the Stanford University School of Medicine. Dr. Fonzo’s research encompasses two main themes. First, his laboratory utilizes non-invasive neuroscience tools such as neuroimaging and neuromodulatory probes to understand neurobiological mechanisms of stress-related mental health disorders such as posttraumatic stress disorder, anxiety, and major depression. Second, his laboratory is focused on designing novel neuroscience-informed interventions to alleviate mental health symptoms, with a particular focus on psychedelic-assisted therapies and neuromodulation. In his clinical practice, he specializes in the assessment and evidence-based psychotherapeutic treatment of posttraumatic stress disorder, anxiety, and depression.
Disclosure: Dr. Fonzo has no financial relationship(s) to disclose.
|
Lunch Break |
|
Lunch: BONUS CE Session: Treatment Share Discussion Glen Baumgart, PhD
Director of Continuing Professional Development The University of Texas at Austin College of Pharmacy |
This optional lunch CE session for in-person attendees includes guided table discussions about topic and treatment changes based on morning topics. Participants may choose a table based on the topic where set questions will be asked and responses discussed focused on the treatment changes and new information learned from previous lectures. Based on topic, case studies will be introduced for discussion. At the close, participants will complete the online assessment asking to summarize what was gained for them through the discussion and to identify one change likely to be made in practice based on the lessons and discussion.
Topic discussions following CE lecture sessions have been shown to significantly increase learner understanding of the presented content and more likely to result in implementation of new practices in patient care.
This is an optional CE program for in-person attendees. In-person attendees may choose to skip the discussions and sit at alternate tables for a networking lunch. Only participants at the designated discussion tables will be eligible for CE credit.
Facilitator: Glen Baumgart, PhD serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy. He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions. Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.
|
Update on Treatment of Bipolar Disorder in Children and Adolescents Karen Dineen Wagner, MD, PhD
Professor and Chair, Department of Psychiatry and Behavioral Sciences
Harry K. Davis Professor, University of Texas Medical Branch
|
Disclosure: Dr. Wagner has no financial relationship(s) to disclose.
|
Break |
|
Substance Use Disorder Update Amanda Simonton, PhD, APRN, PMHNP-BC
Clinical Assistant Professor
The University of Texas at Austin School of Nursing
|
Amanda J. Simonton, PhD, APRN, PMHNP-BC is a Clinical Assistant Professor at the University of Texas at Austin School of Nursing and Psychiatric Mental Health Nurse Practitioner at the Texas Child Study Center at Dell Children’s Medical Center. She has been a Registered Nurse since 2013 and previously worked in the Intermediate Care Unit at Seton Medical Center Austin and Psychiatric Emergency Department at University Medical Center Brackenridge. As a psychiatric nurse practitioner, she has primarily worked with adults with dual-diagnosed (substance use and mental health) disorders and with children and adolescents. She earned her Bachelor of Science in Nursing (’13), Master of Science in Nursing (’18), and Doctor of Philosophy (’20) through the School of Nursing at the University of Texas at Austin. She is active in presenting at the annual conferences for Texas Nurse Practitioners and the American Psychiatric Nurses Association. She is currently on the Policy Council for Texas Nurse Practitioners and the President-Elect on the American Psychiatric Nurses Association Texas Chapter Board of Directors. Dr. Simonton is also a member of two steering committees, which focus on treatment of schizophrenia spectrum disorders and bipolar depression, for Medscape Inc. Her research and clinical interests are to improve the lives of individuals with substance use disorders and serious mental illness by utilizing evidence-based care and best-practices in the field of psychiatry and psychology.
Disclosure: Amanda Simonton has no financial relationship(s) to disclose.
|
Psychotropic New Drug Update Stephen R. Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program Clinical Professor The University of Texas at Austin College of Pharmacy |
Dr. Saklad was born in Los Angeles, California in 1953, and graduated from Pacific Palisades High School in 1970. He received his baccalaureate degree cum laude in Bacteriology from the University of California, Los Angeles in 1974. His Doctor of Pharmacy degree was earned at the University of Southern California in 1978. He had a National Institute of Mental Health training fellowship in Psychiatric Pharmacy supervised by Jim Wilson, Pharm.D., BCPP at the Nebraska Psychiatric Institute of the University of Nebraska Medical Center at Omaha in 1978-9. He then joined the faculty of The University of Texas at Austin College of Pharmacy and the clinical staff at San Antonio State Hospital (SASH) in 1979. He was the first clinical pharmacist employed by the Texas Department of Mental Health and Mental Retardation (now Texas Health and Human Services) when he began as Clinical Coordinator at SASH. He has lived in San Antonio, Texas since 1979. He is married and the father of triplet sons.
During his 38 years career, Dr. Saklad has provided clinical care, education, and research in a variety of settings and treatment roles at SASH. He team teaches didactic courses for second and third professional year pharmacy students. He is the course director for Advanced Pharmacotherapy Laboratory, a third professional year opportunity for students to develop their clinical presentation skills that is given across four campuses. He precepts and mentors third and fourth professional year pharmacy students (P3’s & P4’s) at SASH. He received the UT Austin College of Pharmacy’s Teaching Award from the Class of 2014. He authored and successfully discussed with members of the Texas Legislature the creation of a clinical research unit at SASH that was funded by the Texas Legislature and jointly governed by the UT Austin College of Pharmacy, UT Health Science Center San Antonio Department of Psychiatry and SASH.
Dr. Saklad initiated and developed the first websites for the UT Austin College of Pharmacy in 1994, the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997, and the CPNP Foundation in 2015. He helped to design, organize and was a founding member of CPNP when it incorporated in 1998 as well as the CPNP Foundation in 2012. In 2003, he was elected to the Board of Directors of the CPNP for a two-year term. He has served as a member or officer of the CPNP Communications Committee since the creation of CPNP from 1995 to 2011 and was the Founding Senior Editor of the Mental Health Clinician, CPNP’s Open Access journal, from 2011-13. Currently, Dr. Saklad is Treasurer of the CPNP Foundation a member of the CPNP Business Development Committee. He was on the task force that developed The Mental Health Pharmacy Directory to improve patient access. He is the Director of The University of Texas Psychiatric Pharmacy Program. In 1988, he helped to create and has chaired The University of Texas at Austin College of Pharmacy’s Psychiatric Pharmacotherapy Update since 2007.
Dr. Saklad publishes articles and presents to many groups around the country on a variety of pharmacy and mental health-related topics. He edited Psychopharmacology Update newsletter from 1998-2002 and edited two editions of a compendium based upon this newsletter, Psychopharmacology Desktop Reference, published by Manisses Communications Group in 1999 and 2002. He provides updates on his Twitter feed on a variety of topics @pharmacopsych.
Dr. Saklad is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, depression, and other serious and persistent mental illness, as well as their pharmacokinetics and interactions. He was the Director of UT Health Science Center San Antonio’s Advanced Pharmacotherapy Research with research facilities located at Laurel Ridge Treatment Center and President of Alamo Superior Research, LLC. He has been affiliated with the Behavioral Wellness (“Be Well”) Center, Department of Psychiatry, UT Health San Antonio since 2009.
Disclosure: Dr. Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
|
Day 1 Concludes
|
|
Reception |
|
Welcome to the 34th Psychiatric Pharamcotherapy Update
|
|
In-Person Check-In |
|
Breakfast |
|
34th Psychiatric Pharamcotherapy Update Opening Remarks
|
|
Complementary and Integrative Health (CIH) Update Claudia Voyles, DAOM, LAc
WH&IHS Acupuncturist CTVHSC, Karisha ONE Remedy Center for Healing Arts, Inc.
|
Disclosure: Claudia Voyles has no financial relationship(s) to disclose.
|
Update on Treatment Resistant Depression in Adults Madhukar Trivedi, MD
Professor, Chief of the Division of Mood Disorders Director of the Comprehensive Center for Depression
Department of Psychiatry, UT Southwestern Medical Center
|
Madhukar Trivedi, M.D., is a Professor of Psychiatry, Chief of the Division of Mood Disorders, and founding Director of the Center for Depression Research and Clinical Care at UT Southwestern Medical Center, where he holds the Betty Ho Hay Distinguished Chair in Mental Health and the Julie K. Hersh Chair for Depression Research and Clinical Care. Certified by the American Board of Psychiatry and Neurology, Dr. Trivedi focuses on developing and validating biosignatures of depression. He also conducts research on pharmacological, psychosocial, and nonpharmacological treatments for depression. He has been a principal investigator on numerous translational research projects and clinical trials. He serves on the editorial board of CNS Spectrums, Clinical Medicine: Psychiatry, Journal of Clinical Psychiatry, Journal of Affective Disorders, Psychiatric Annals and Asian Journal of Psychiatry. Dr. Trivedi currently serves as Deputy Editor of the American Journal of Psychiatry and as president of the American Society of Clinical Psychopharmacology (ASCP). He is a member of numerous other organizations, including the The American Brain Coalition, American College of Neuropsychopharmacology, American College of Psychiatrists, American Medical Association, American Psychiatric Association, Dallas County Medical Society, Society of Biological Psychiatry, Texas Medical Association, and the Texas Society of Psychiatric Physicians. Named a Texas Monthly Super Doctor multiple times, he has received numerous accolades, including the Gerald L. Klerman Award from the National Depressive and Manic-Depressive Association Scientific Advisory Board, the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians, the Gerald Klerman Senior Investigator Award, the American Psychiatric Association Award for Research, and the Mood Disorders Research Award from the American College of Psychiatrists. Dr. Trivedi was listed by Thomson Reuters’ World’s Most Influential Scientific Minds as one of the nation’s most highly cited researchers in psychiatry every year since 2014.
Disclosure: Dr. Trivedi has no financial relationship(s) to disclose.
|
Break |
|
Clinical Controversies in Catatonia Mark Messer, D.O.
Superintendent and Medical Director
Terrell State Hospital
Health & Specialty Care System/Texas Health and Human Services
|
Bio:
Disclosure: Dr. Messer has no financial relationship(s) to disclose.
|
Lunch Break |
|
Lunch: BONUS CE Session: Treatment Share Discussion Glen Baumgart, PhD
Director of Continuing Professional Development The University of Texas at Austin College of Pharmacy |
This optional lunch CE session for in-person attendees includes guided table discussions about topic and treatment changes based on morning topics. Participants may choose a table based on the topic where set questions will be asked and responses discussed focused on the treatment changes and new information learned from previous lectures. Based on topic, case studies will be introduced for discussion. At the close, participants will complete the online assessment asking to summarize what was gained for them through the discussion and to identify one change likely to be made in practice based on the lessons and discussion.
Topic discussions following CE lecture sessions have been shown to significantly increase learner understanding of the presented content and more likely to result in implementation of new practices in patient care.
This is an optional CE program for in-person attendees. In-person attendees may choose to skip the discussions and sit at alternate tables for a networking lunch. Only participants at the designated discussion tables will be eligible for CE credit.
Facilitator: Glen Baumgart, PhD serves as Director of the Center for Continuing Professional Development at The University of Texas at Austin College of Pharmacy. He holds a doctorate in educational psychology and has extensive experience in managing education discussion sessions. Disclosure: Dr. Baumgart has no financial relationship(s) to disclose.
|
Treatment Update on Obsessive Compulsive Disorder Samantha Catanzono, PharmD, BCPP
Clinical Assistant Professor of Pharmacy Practice The University of Texas at Austin College of Pharmacy
|
Disclosure: Dr. Catanzano has no financial relationship(s) to disclose.
|
Break |
|
Antipsychotics in Pregnancy and Lactation Jeffrey Newport, M.D.
Director of Women’s Reproductive Mental Health
UT Health Austin
|
Jeffrey Newport is Professor of Psychiatry and Women’s Health at the University of Texas at Austin Dell Medical School where he serves as Associate Chair for Research for the Department of Psychiatry & Behavioral Sciences and Director of Texas Women’s Reproductive Mental Health.. Dr. Newport completed a graduate theological degree before receiving his medical degree from the University of South Carolina. He subsequently completed psychiatric residency and a master’s degree in clinical research at Emory University. His awards include the NARSAD Independent and Young Investigator Awards, Young Faculty Award from the American Psychiatric Institute for Research and Education, the Society of Biological Psychiatry’s Lilly Fellowship, the American College of Psychiatrists’ Laughlin Fellowship, and the Distinguished Physician Alumnus Award from the University of South Carolina. He has published in leading journals across numerous specialties including JAMA, American Journal of Psychiatry, American Journal of Obstetrics & Gynecology, Neurology, and Pediatrics. Dr. Newport’s research focuses on women’s mental health with an emphasis on the psychobiology of perinatal psychiatric disorders, psychotropic pharmacokinetics during pregnancy and lactation, and the persistent biobehavioral impact of childhood trauma and other early life adverse experiences.
Disclosure: Dr. Newport has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
|
RAISE Your Communication: Elevating and Updating Your Clinical Language K. Ashley Garling Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
President Capital Area Pharmacist Association
Morgan P. Stewart, PharmD, BCACP
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
|
Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning from telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.
Disclosure: Dr. Garling has no financial relationship(s) to disclose.
Stewart Bio: Coming soon
Disclosure: TBA
 Overall Conference Evaluation |
|
Day 2 Concludes • Conference Adjourns
|
 On-Demand Sessions Start Here |
|
Dan Arendt, Pharm.D., BCPS
Assistant Professor – Pain Stewardship
The James L. Winkle College of Pharmacy
University of Cincinnati & UC Health
|
|
K. Ashley Garling Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy
President Capital Area Pharmacist Association
Kaitlin Berns, MPH, RD
Program Coordinator, Center for Health Communications
The University of Texas at Austin Moody College of Communications
Thea Woodruff, PhD
Project Coordinator, Well-being in Learning Environments Counseling and Mental Health Center, University of Texas at Austin |
|
Samantha Catanzono, PharmD, BCPP
Clinical Assistant Professor of Pharmacy Practice The University of Texas at Austin College of Pharmacy
|
Disclosure: Dr. Catanzano has no financial relationship(s) to disclose.
|
M. Lynn Crismon, PharmD, FCCP, DABCP, BCPP
Behrens Centennial Professor of Pharmacy
The University of Texas at Austin College of Pharmacy |
M. Lynn Crismon is the Behrens Centennial Professor of Pharmacy and Professor of Psychiatry at The University of Texas at Austin and past Dean and James T. Doluisio Regents Chair of the
College of Pharmacy. He is board certified in psychiatric pharmacy and a Diplomate of the American Board of Clinical Pharmacology. His research has focused on improving the pharmacotherapy of severe mental disorders and mental health outcomes research. He has 268 publications and over 207 abstracts. He has supervised 39 psychiatric pharmacy residents, research fellows, or graduate students. He is a founding steering committee member and faculty member in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives. He is a recipient of the ACCP Paul F. Parker Medal and the ASHP Board of Directors Distinguished Leadership Award.
|
Sara Rogers, PharmD
Director of Clinical Affairs
American Society of Pharmacovigilance
|
Sara Rogers serves as Clinical Assistant Professor of Precision Medicine and Ambulatory Care at Irma Lerma Rangel College of Pharmacy, Texas A&M University and Clinical Specialist at Texas A&M Physicians Clinic. She co-founded the American Society of Pharmacovigilance, where she led the Society’s clinical, research and educational initiatives. Rogers co-led the formation of the Pharmacogenomics Access and Reimbursement Coalition and collaboratively developed the Coalition’s research agenda to understand the payment and policy landscape for pharmacogenetics testing and its role in disparities in patient access. Rogers serves as an organizational member of the NIH National Human Genomics Research Institute Inter-Society Coordinating Committee and develops educational resources to help practitioners navigate coverage for pharmacogenetics testing. Her research track record reveals a long-standing goal of informing policy and practice. Dr. Rogers has served as co-investigator for a pilot study to identify ethical values and priorities related to pharmacogenomics. Her research focuses extensively on patient access to and reimbursement for pharmacogenetics testing. Rogers co-led the formation of the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, a public-private multidisciplinary initiative to develop consensus-based industry standards for pharmacogenetics testing. Prior to serving in these roles, Rogers was an Ambulatory Treatment Center pharmacist at MD Anderson Cancer Center where she led team-based research projects to optimize workflow and screening protocols throughout the division of pharmacy.
Disclosure: Sara Rogers does not have any relevant financial relationship(s) with ineligible companies
|
HOLD - Exhibitor Space
|
|
HOLD - Exhibitor Space
|
|
HOLD - Exhibitor Space
|
|
HOLD - Exhibitor Space
|